Artikel
Short-term results of Revision Cubital Tunnel Release Treated With Neurolysis and Procine Submucosa Extracellular Matrix
Suche in Medline nach
Autoren
Veröffentlicht: | 6. Februar 2020 |
---|
Gliederung
Text
Objectives/Interrogation: Epineural scarring following decompression of a peripheral nerve results in significant morbidity. We report a single institution experience of using procine submucosa extracellular matrix (AxoGuard® AxoGen Inc., Alachua FL) in revision Cubital tunnel release.
Methods: Twenty-four patients with recurrent ulnar nerve compression neuropathy at the elbow were treated with revision cubital tunnel release, neurolysis and AxoGuard® nerve wrapping. Idiopathic cubital tunnel syndrome was the primary operation in 16 cases and 9 had primary ulnar decompression following elbow trauma. Patient demographics, pre-and post-operative pain scores, sensory function, Tinel's sign and patient satisfaction were recorded in each case.
Results and Conclusions: All patients were followed up to an average of 6 months (range 3-40), mean age of patients 50 was years (range 27-75). Post-operative pain levels improved from 7 to 3 (p<0.05) and sensation improved from a mean of 4 to 8. Following revision surgery absence of Tinel's sign was noted in 18 patients. One case had early re-exploration due to a wound haematoma. There were no complications associated with the use of the porcine submucosa extracellular matrix as a nerve wrap.
In this series of revision cubital tunnel decompression and neurolysis the addition of an AxoGuard® demonstrated good clinical results with no complications.